78. 下垂体前葉機能低下症 Hypopituitarism Clinical trials / Disease details

臨床試験数 : 492 / 薬物数 : 341 - (DrugBank : 47) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 100

48 trials found

diseases per page:

Showing 1 to 10 of 48 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-000929-42-NL (EUCTR)	14/04/2022	23/02/2021	Trial to compare the efficacy and safety of once-weekly lonapegsomatropin with placebo and a daily s ...	foresiGHt: A multicenter, randomized, parallel-arm, placebo- controlled (double- blind) and active-c ...	Adult Growth Hormone Deficiency (AGHD) MedDRA version: 20.0;Level: PT;Classification code 10056438;T ...	Product Name: lonapegsomatropin drug product Product Code: ACP-011 INN or Proposed INN: LONAPEGSOMATROP ...	Ascendis Pharma Endocrinology Division A/S	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	240	Phase 3	Serbia;Belarus;United States;Slovakia;Greece;Spain;Ukraine;Turkey;Israel;United Kingdom;Italy;France ...
2	EUCTR2020-000929-42-BG (EUCTR)	07/01/2022	20/01/2021	Trial to compare the efficacy and safety of once-weekly lonapegsomatropin with placebo and a daily s ...	foresiGHt: A multicenter, randomized, parallel-arm, placebo- controlled (double- blind) and active-c ...	Adult Growth Hormone Deficiency (AGHD) MedDRA version: 20.0;Level: PT;Classification code 10056438;T ...	Product Name: lonapegsomatropin drug product Product Code: ACP-011 INN or Proposed INN: LONAPEGSOMATROP ...	Ascendis Pharma Endocrinology Division A/S	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	240	Phase 3	Serbia;Belarus;United States;Slovakia;Greece;Spain;Ukraine;Israel;Italy;France;Australia;Denmark;Net ...
3	EUCTR2020-000929-42-DK (EUCTR)	05/08/2021	12/01/2021	Trial to compare the efficacy and safety of once-weekly lonapegsomatropin with placebo and a daily s ...	foresiGHt: A multicenter, randomized, parallel-arm, placebo- controlled (double- blind) and active-c ...	Adult Growth Hormone Deficiency (AGHD) MedDRA version: 20.0;Level: PT;Classification code 10056438;T ...	Product Name: lonapegsomatropin drug product Product Code: ACP-011 INN or Proposed INN: LONAPEGSOMATROP ...	Ascendis Pharma Endocrinology Division A/S	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	240	Phase 3	United States;Belarus;Serbia;Slovakia;Greece;Spain;Ukraine;Israel;Russian Federation;Italy;France;Au ...
4	EUCTR2020-000929-42-DE (EUCTR)	09/06/2021	14/10/2020	Trial to compare the efficacy and safety of once-weekly lonapegsomatropin with placebo and a daily s ...	foresiGHt: A multicenter, randomized, parallel-arm, placebo- controlled (double- blind) and active-c ...	Adult Growth Hormone Deficiency (AGHD) MedDRA version: 20.0;Level: PT;Classification code 10056438;T ...	Product Name: lonapegsomatropin drug product Product Code: ACP-011 INN or Proposed INN: LONAPEGSOMATROP ...	Ascendis Pharma Endocrinology Division A/S	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	240	Phase 3	United States;Belarus;Serbia;Slovakia;Greece;Spain;Ukraine;Israel;Russian Federation;Italy;France;Au ...
5	EUCTR2020-000929-42-ES (EUCTR)	21/04/2021	01/02/2021	Trial to compare the efficacy and safety of once-weekly lonapegsomatropin with placebo and a daily s ...	foresiGHt: A multicenter, randomized, parallel-arm, placebo- controlled (double- blind) and active-c ...	Adult Growth Hormone Deficiency (AGHD) MedDRA version: 20.0;Level: PT;Classification code 10056438;T ...	Product Name: lonapegsomatropin drug product Product Code: ACP-011 INN or Proposed INN: LONAPEGSOMATROP ...	Ascendis Pharma Endocrinology Division A/S	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	240	Phase 3	Serbia;Belarus;United States;Slovakia;Greece;Spain;Ukraine;Israel;Italy;France;Australia;Denmark;Net ...
6	EUCTR2020-000929-42-SK (EUCTR)	12/04/2021	24/11/2020	Trial to compare the efficacy and safety of once-weekly lonapegsomatropin with placebo and a daily s ...	foresiGHt: A multicenter, randomized, parallel-arm, placebo- controlled (double- blind) and active-c ...	Adult Growth Hormone Deficiency (AGHD) MedDRA version: 20.0;Level: PT;Classification code 10056438;T ...	Product Name: lonapegsomatropin drug product Product Code: ACP-011 INN or Proposed INN: LONAPEGSOMATROP ...	Ascendis Pharma Endocrinology Division A/S	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	240	Phase 3	Serbia;Belarus;United States;Slovakia;Greece;Spain;Ukraine;Russian Federation;Israel;Italy;France;Au ...
7	EUCTR2020-000929-42-GR (EUCTR)	23/03/2021	04/03/2021	foresiGHt: A multicenter, randomized, parallel-arm, placebo- controlled (double- blind) and active-c ...	foresiGHt: A multicenter, randomized, parallel-arm, placebo- controlled (double- blind) and active-c ...	Adult Growth Hormone Deficiency (AGHD) MedDRA version: 20.0;Level: PT;Classification code 10056438;T ...	Product Name: lonapegsomatropin drug product Product Code: ACP-011 INN or Proposed INN: LONAPEGSOMATROP ...	Ascendis Pharma Endocrinology Division A/S	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	240	Phase 3	Belarus;Serbia;United States;Slovakia;Greece;Spain;Ukraine;Israel;Russian Federation;Italy;France;De ...
8	EUCTR2016-001145-11-DE (EUCTR)	12/02/2018	14/12/2016	A trial of TransCon hGH, a sustained-release recombinant human growth hormone product, for treatment ...	A multicenter, Phase 3, randomized, open-label, active-controlled, parallel-group trial investigatin ...	Growth hormone deficiency (GHD) in prepubertal children MedDRA version: 20.0;Level: PT;Classificatio ...	Product Name: TransCon hGH (ACP-011) - 12.1mg INN or Proposed INN: lonapegsomatropin Other descriptive ...	Ascendis Pharma Endocrinology Division A/S	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	Lebanon;Russian Federation;Chile;Azerbaijan;Italy;France;Jordan;Australia;South Africa;Lithuania;Tur ...
9	EUCTR2016-001145-11-IT (EUCTR)	07/04/2017	10/01/2017	A multicenter, Phase 3, randomized, open-label, active-controlled, parallel-group trial investigatin ...	A multicenter, Phase 3, randomized, open-label, active-controlled, parallel-group trial investigatin ...	Growth hormone deficiency (GHD) in prepubertal children MedDRA version: 19.1;Level: PT;Classificatio ...	Product Name: TransCon hGH CT-301 (ACP-011) - 12,1mg INN or Proposed INN: TransCon hGH (ACP-011) Other ...	Ascendis Pharma Endocrinology Division A/S	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	United States;Belarus;Greece;Kyrgyzstan;Spain;Ukraine;Lebanon;Chile;Russian Federation;Azerbaijan;It ...
10	EUCTR2016-001145-11-PL (EUCTR)	31/03/2017	17/01/2017	A multicenter, Phase 3, randomized, open-label, active-controlled, parallel-group trial investigatin ...	A multicenter, Phase 3, randomized, open-label, active-controlled, parallel-group trial investigatin ...	Growth hormone deficiency (GHD) in prepubertal children MedDRA version: 20.0;Level: PT;Classificatio ...	Product Name: TransCon hGH (ACP-011) - 12.1mg INN or Proposed INN: lonapegsomatropin Other descriptive ...	Ascendis Pharma Endocrinology Division A/S	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	United States;Belarus;Greece;Kyrgyzstan;Spain;Ukraine;Lebanon;Chile;Russian Federation;Azerbaijan;It ...

First Previous1 2 3 4 5Next Last